AAAAAA
Results:
1-21
|
Results: 21
Authors:
Khayat, D
Gil-Delgado, M
Antoine, EC
Nizri, D
Bastian, G
Citation: D. Khayat et al., The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer, ONCOLOGY-NY, 15(4), 2001, pp. 415-429
Authors:
Khayat, D
Chollet, P
Antoine, EC
Monfardini, S
Ambrosini, G
Benhammouda, A
Mazen, MF
Sorio, R
Borg-Olivier, O
Ramazeilles, C
Azli, N
Citation: D. Khayat et al., Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breastcancer, J CL ONCOL, 19(14), 2001, pp. 3367-3375
Authors:
Gil-Delgado, MA
Antoine, EC
Guinet, F
Bassot, V
Grapin, JP
Benhammonda, A
Adam, R
Castaing, D
Bismuth, H
Khayat, D
Citation: Ma. Gil-delgado et al., Phase I-II study of irinotecan in combination with mitomycin C in patientswith advanced gastrointestinal cancer, AM J CL ONC, 24(3), 2001, pp. 251-254
Authors:
Gil-Delgado, MA
Guinet, F
Castaing, D
Adam, R
Coeffic, D
Durrani, AKS
Bismuth, H
Khayat, D
Citation: Ma. Gil-delgado et al., Prospective phase II trial of irinotecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer, AM J CL ONC, 24(1), 2001, pp. 101-105
Authors:
Khayat, D
Citation: D. Khayat, Optimising, the role of Herceptin (R) in breast cancer - Proceedings of a symposium, Monte Carlo, June 19-21, 2000 - Preface, ONCOL-BASEL, 61, 2001, pp. IV-IV
Authors:
Mouawad, R
Antoine, EC
Khayat, D
Soubrane, C
Citation: R. Mouawad et al., Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expressionin advanced melanoma patients, CYTOK CELL, 6(3), 2000, pp. 135-140
Authors:
Mouawad, R
Khayat, D
Soubrane, C
Citation: R. Mouawad et al., Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma, MELANOMA RE, 10(5), 2000, pp. 461-467
Authors:
Fauser, AA
Pizzocaro, G
Schueller, J
Khayat, D
Wilkinson, P
Citation: Aa. Fauser et al., A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management offractionated cisplatin-related nausea and vomiting, SUPP CARE C, 8(1), 2000, pp. 49-54
Authors:
Negrier, S
Fervers, B
Bailly, C
Beckendorf, V
Cupissol, D
Dore, JF
Garbay, JR
Vilmer, C
Borel, C
Boulier, N
Cabarrot, E
Carrie, C
Chevreau, C
de Cislain, C
Delaunay, MM
Depardieu, C
Dubois, JB
Escande, MC
Fraisse, J
Parache, RM
Philip, T
Ravaud, A
Sancho-Garnier, H
Spatz, A
Autier, P
Bonnetblanc, JM
de Raucourt, S
Dreno, B
Gouttebel, MC
Grange, F
Guillot, B
Khayat, D
Lehmann, M
Leroy, D
Regal, R
Revuz, J
Saiag, P
Schmutz, JL
Truchetet, F
Vuillemin, P
Citation: S. Negrier et al., Standards, options and guidelines for caring for patients with cutaneous melanomas, PRESSE MED, 29(23), 2000, pp. 1317-1326
Authors:
Khayat, D
Antoine, EC
Coeffic, D
Citation: D. Khayat et al., Taxol in the management of cancers of the breast and the ovary, CANCER INV, 18(3), 2000, pp. 242-260
Authors:
Perez-Manga, G
Lluch, A
Alba, E
Moreno-Nogueira, JA
Palomero, M
Garcia-Conde, J
Khayat, D
Rivelles, N
Citation: G. Perez-manga et al., Gemcitabine in combination with doxorubicin in advanced breast cancer: Final results of a phase II pharmacokinetic trial, J CL ONCOL, 18(13), 2000, pp. 2545-2552
Authors:
Spano, JP
Taillibert, S
Khayat, D
Terrier, P
Citation: Jp. Spano et al., Hibernoma, an uncommun tumor as a differential diagnosis of liposarcoma ofthe thigh, ANTICANC R, 20(6C), 2000, pp. 4803-4804
Authors:
Taillibert, S
Spano, JP
Genestie, C
Khayat, D
Citation: S. Taillibert et al., A mesocolic leiomyosarcoma metastatic to the breast: Case report and review of the literature, ANTICANC R, 20(6C), 2000, pp. 4867-4869
Authors:
Hortobagyi, GN
Khayat, D
Citation: Gn. Hortobagyi et D. Khayat, Targeting progress: The development of growth factor receptor-directed therapy, SEMIN ONCOL, 27(5), 2000, pp. 1-2
Authors:
Khayat, D
Citation: D. Khayat, Is anemia a problem for European cancer patients and treating oncologists?, SEMIN ONCOL, 27(2), 2000, pp. 9-11
Authors:
Soubrane, C
Mouawad, R
Antoine, EC
Verola, O
Gil-Delgado, M
Khayat, D
Citation: C. Soubrane et al., A comparative study of Fas and Fas-ligand expression during melanoma progression, BR J DERM, 143(2), 2000, pp. 307-312
Authors:
Mouawad, R
Khayat, D
Merle, S
Antoine, EC
Gil-Delgado, M
Soubrane, C
Citation: R. Mouawad et al., Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?, MELANOMA RE, 9(2), 1999, pp. 181-188
Authors:
Buthiau, D
Antoine, EC
Lapresle, P
Wechsler, B
Missenard, G
Misset, JL
Denarnaud, J
Khayat, D
Ziza, JM
Citation: D. Buthiau et al., Clinical imaging of osteodense metastasis., REV MED IN, 20(4), 1999, pp. 353-364
Authors:
Bouaud, J
Seroussi, B
Antoine, EC
Gozy, M
Khayat, D
Boisvieux, JF
Citation: J. Bouaud et al., Patient-centred consultation of clinical practice guidelines: OncoDoc, a decision support system for the management of breast cancer patients, THERAPIE, 54(2), 1999, pp. 209-215
Authors:
Buthiau, D
Antoine, EC
Khayat, D
Citation: D. Buthiau et al., Virtual endoscopy in oncology, PROG ANTI C, 2, 1999, pp. 15-27
Authors:
Ducreux, M
Gil-Delgado, M
Andre, T
Ychou, M
de Gramond, A
Khayat, D
Citation: M. Ducreux et al., Combination of irinotecan and other drugs in the treatment of colorectal metastatic cancer, B CANCER, 1998, pp. 43-46
Risultati:
1-21
|